התחייבויות לטווח ארוך להון ChromaDex (CDXC)

The market dynamics of ChromaDex Corporation (CDXC) reflect the performance of a company leading the NAD+ booster segment and expanding B2B supplies for behemoths such as Nestle. The current value of the metric is 0.04. The business relies on stable demand within the defensive sector, which offsets inflationary risks. The scaling model is based on licensing unique patents, allowing the company to generate profit without incurring retail marketing costs.

This indicator assesses the financial stability of ChromaDex Corporation (CDXC) through the ratio of long-term liabilities to equity. The metric determines the degree of the business's dependence on external borrowed financing with a maturity exceeding one year. By analyzing long-term debt relative to equity, an investor can see the balance between credit risk and growth rates. A reduction in leverage confirms the ability of ChromaDex Corporation (CDXC) to independently finance the implementation of ESG environmental standards. The optimization of dietary supplement production and the transition to recyclable packaging require stable capital without excessive pressure from creditors.